Pain Management News

Pain may influence cancer survivors’ decisions to use tobacco or cannabis, according to results of a retrospective analysis.

The FDA approved 16 psychiatric drugs over the last decade, most of which shared similar mechanisms of action with previously developed drugs, according to data in a research latter published in JAMA Network Open.

The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a press release.

Adults aged 18 to 49 years who used cannabis for medical reasons had higher rates of cannabis use disorder compared with adults who only used cannabis recreationally, according to a research letter published in JAMA Psychiatry.

Although state laws have expanded access to naloxone, overdose deaths among adolescents and young adults continue to climb, according to data published in JAMA Pediatrics.

Guidelines for cannabis and prescription opioid use in the management of cancer-associated pain should reflect changing patient attitudes toward these approaches, according to study findings.

Individuals with narcolepsy were significantly more likely to have sleep, mood and pain disorders compared with matched controls, indicating where treatment may best target common comorbidities, according to new research from Sleep Advances.

Primary care providers can use self-assessments and other resources to diagnose medically unexplained chronic symptoms and offer relief for patients, according to an expert.

Medical marijuana use led to improvements in health-related quality of life among adults referred for medical marijuana by a physician to treat qualifying medical conditions, according to a study published in Journal of Cannabis Research.